Ensuring Access to Lower-Cost Medicines for Seniors Act requires Medicare Part D plans to include generic drugs and biosimilar biological products on.
The Ensuring Access to Lower-Cost Medicines for Seniors Act amends the Social Security Act to mandate that Medicare Part D plans include generic drugs and biosimilar biological products on their formularies. Starting from January 1, 2028, plans must have at least one cost-sharing tier that includes only generic drugs and biosimilar biological products. These products must be included on formularies if they have a lower wholesale acquisition cost than their reference drugs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.